Article Text

Download PDFPDF
Earlier identification of seriously ill patients: an implementation case series
  1. Joshua R Lakin1,
  2. Meghna Desai1,
  3. Kyle Engelman1,
  4. Nina O'Connor2,
  5. Winifred G Teuteberg3,
  6. Alison Coackley4,
  7. Laurel B Kilpatrick5,
  8. Atul Gawande1 and
  9. Erik K Fromme1
  1. 1Ariadne Labs, Boston, Massachusetts, USA
  2. 2Palliative and Hospice Medicine, University of Pennsylvania Perelman School of Medicine, Philadelphia, Pennsylvania, USA
  3. 3Section of Palliative Medicine, Stanford University School of Medicine, Palo Alto, California, USA
  4. 4Clatterbridge Cancer Centre NHS Foundation Trust, Bebington, UK
  5. 5Division of Supportive and Palliative Care, Baylor Scott & White Health, Temple, Texas, USA
  1. Correspondence to Dr Joshua R Lakin, Ariadne Labs, Boston, MA 02215, USA; jlakin{at}partners.org

Footnotes

  • Contributors JRL and EKF take responsibility for the integrity of the cases reported in this manuscript.

  • Funding This work was supported by the Gordon and Betty Moore Foundation.

  • Disclaimer See ICMJE COI statement.

  • Competing interests AG reports receiving royalties from publishers and media outlets worldwide for writing and other media on healthcare including the subject of serious illness care and checklists during the conduct of this study. AG is also employed as the CEO of the new non-profit-seeking healthcare venture parented by Amazon, Berkshire Hathaway and JP Morgan Chase. JRL reports grants from The Gordon and Betty Moore Foundation, during the conduct of the study; grants from Cambia Health Foundation, outside the submitted work; and JRL receives salary support funding for work related to the Serious Illness Care Program (studied in this manuscript) from his home institutions. Additionally, he receives teaching honoraria related to his academic work on the Program from government and academic entities. EKF reports grants and other from the Gordon and Betty Moore Foundation during the conduct of this study, and is the Director of the Serious Illness Care Program, the quality improvement program referenced in the paper.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as online supplementary information.

View Full Text

Statistics from Altmetric.com

Footnotes

  • Contributors JRL and EKF take responsibility for the integrity of the cases reported in this manuscript.

  • Funding This work was supported by the Gordon and Betty Moore Foundation.

  • Disclaimer See ICMJE COI statement.

  • Competing interests AG reports receiving royalties from publishers and media outlets worldwide for writing and other media on healthcare including the subject of serious illness care and checklists during the conduct of this study. AG is also employed as the CEO of the new non-profit-seeking healthcare venture parented by Amazon, Berkshire Hathaway and JP Morgan Chase. JRL reports grants from The Gordon and Betty Moore Foundation, during the conduct of the study; grants from Cambia Health Foundation, outside the submitted work; and JRL receives salary support funding for work related to the Serious Illness Care Program (studied in this manuscript) from his home institutions. Additionally, he receives teaching honoraria related to his academic work on the Program from government and academic entities. EKF reports grants and other from the Gordon and Betty Moore Foundation during the conduct of this study, and is the Director of the Serious Illness Care Program, the quality improvement program referenced in the paper.

  • Patient consent for publication Not required.

  • Provenance and peer review Not commissioned; externally peer reviewed.

  • Data availability statement All data relevant to the study are included in the article or uploaded as online supplementary information.

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.